- Tarsons Products IPO opens today and closes on November 17.
- The company is looking to raise ₹1,024 crore through its public listing of shares.
- The grey market premium of the Indian labware company is at a premium of ₹200 per share in the grey market.
The company is looking to raise ₹1,024 crore through its public listing of shares with a fresh issue of equity shares worth ₹150 crore and an offer for sale (OFS) of 1.32 crore equity shares that will be sold by promoters and an investor.
Tarsons Products has raised ₹305.96 crore from anchor investors at the upper price band of ₹662 per equity share ahead of its issue.
Here are important dates related to the IPO:
In the IPO, promoter Sanjive Sehgal will offload up to 3.9 lakh equity shares, Rohan Sehgal will sell up to 3.1 lakh equity shares and investor Clear Vision Investment Holdings will divest up to 1.25 crore equity shares.
The company will utilise the proceeds from the fresh issue towards paying debt, funding a part of the capital expenditure for the new manufacturing facility at Panchla in West Bengal and general corporate purposes.
Tarsons Products is engaged in designing, developing, manufacturing and supplying a diverse range of quality labware products used in laboratories across research organisations, academic institutes, pharmaceutical firms, diagnostics companies and hospitals. It manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare. The company currently operates through its five manufacturing facilities located in West Bengal.
SEE ALSO: